Research led by Seng Chan You, MD, at the Yonsei University College of Medicine, Korea, has investigated the risk of cancer associated with use of the drug ranitidine compared to other histamine-2 ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Hosted on MSN
What Documents Do You Need to File a Zantac Claim?
Filing a Zantac claim is a crucial step toward securing justice and financial relief for those affected. By gathering essential documents, such as medical records, prescription proof, and evidence of ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
In a significant legal win for GSK plc (NYSE:GSK), on Friday, a Florida State Court ruled in favor of the pharmaceutical giant, excluding the plaintiff’s expert testimonies that claimed ranitidine, a ...
Over the counter medication use is the norm in the United States, with nine out of 10 people using OTC options on a regular basis. Most popular OTC medications include acetaminophen (Tylenol) and ...
A researcher prepares to test a bottle of Zantac 150 at the Valisure LLC lab in New Haven, Connecticut, US on Wednesday, Sept. 7, 2022. A meta-analysis suggests that ranitidine does not pose an ...
As the US Food and Drug Administration (FDA) continues to test ranitidine products, including the popular heartburn medicine Zantac, from multiple manufacturers for the carcinogen ...
Drugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing ...
Jan 22 (Reuters) - GSK (GSK.L), opens new tab, Pfizer (PFE.N), opens new tab and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want ...
Hosted on MSN
Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits
New Delhi: There is no plan to ban the manufacture and sale of ranitidine despite concerns over N-nitrosodimethylamine (NDMA), an impurity in the drug which has been found to degrade into a probable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results